BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20028790)

  • 1. The genetic and metabolic signature of oncocytic transformation implicates HIF1alpha destabilization.
    Porcelli AM; Ghelli A; Ceccarelli C; Lang M; Cenacchi G; Capristo M; Pennisi LF; Morra I; Ciccarelli E; Melcarne A; Bartoletti-Stella A; Salfi N; Tallini G; Martinuzzi A; Carelli V; Attimonelli M; Rugolo M; Romeo G; Gasparre G
    Hum Mol Genet; 2010 Mar; 19(6):1019-32. PubMed ID: 20028790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation threshold distinguishes the antitumorigenic effects of the mitochondrial gene MTND1, an oncojanus function.
    Gasparre G; Kurelac I; Capristo M; Iommarini L; Ghelli A; Ceccarelli C; Nicoletti G; Nanni P; De Giovanni C; Scotlandi K; Betts CM; Carelli V; Lollini PL; Romeo G; Rugolo M; Porcelli AM
    Cancer Res; 2011 Oct; 71(19):6220-9. PubMed ID: 21852384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial mutations contribute to HIF1alpha accumulation via increased reactive oxygen species and up-regulated pyruvate dehydrogenease kinase 2 in head and neck squamous cell carcinoma.
    Sun W; Zhou S; Chang SS; McFate T; Verma A; Califano JA
    Clin Cancer Res; 2009 Jan; 15(2):476-84. PubMed ID: 19147752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions.
    Brière JJ; Favier J; Bénit P; El Ghouzzi V; Lorenzato A; Rabier D; Di Renzo MF; Gimenez-Roqueplo AP; Rustin P
    Hum Mol Genet; 2005 Nov; 14(21):3263-9. PubMed ID: 16195397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells.
    Selak MA; Durán RV; Gottlieb E
    Biochim Biophys Acta; 2006; 1757(5-6):567-72. PubMed ID: 16797480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different mtDNA mutations modify tumor progression in dependence of the degree of respiratory complex I impairment.
    Iommarini L; Kurelac I; Capristo M; Calvaruso MA; Giorgio V; Bergamini C; Ghelli A; Nanni P; De Giovanni C; Carelli V; Fato R; Lollini PL; Rugolo M; Gasparre G; Porcelli AM
    Hum Mol Genet; 2014 Mar; 23(6):1453-66. PubMed ID: 24163135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruptive mitochondrial DNA mutations in complex I subunits are markers of oncocytic phenotype in thyroid tumors.
    Gasparre G; Porcelli AM; Bonora E; Pennisi LF; Toller M; Iommarini L; Ghelli A; Moretti M; Betts CM; Martinelli GN; Ceroni AR; Curcio F; Carelli V; Rugolo M; Tallini G; Romeo G
    Proc Natl Acad Sci U S A; 2007 May; 104(21):9001-6. PubMed ID: 17517629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An inherited mitochondrial DNA disruptive mutation shifts to homoplasmy in oncocytic tumor cells.
    Gasparre G; Iommarini L; Porcelli AM; Lang M; Ferri GG; Kurelac I; Zuntini R; Mariani E; Pennisi LF; Pasquini E; Pasquinelli G; Ghelli A; Bonora E; Ceccarelli C; Rugolo M; Salfi N; Romeo G; Carelli V
    Hum Mutat; 2009 Mar; 30(3):391-6. PubMed ID: 19086058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E; Porcelli AM; Gasparre G; Biondi A; Ghelli A; Carelli V; Baracca A; Tallini G; Martinuzzi A; Lenaz G; Rugolo M; Romeo G
    Cancer Res; 2006 Jun; 66(12):6087-96. PubMed ID: 16778181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors.
    Xiao M; Yang H; Xu W; Ma S; Lin H; Zhu H; Liu L; Liu Y; Yang C; Xu Y; Zhao S; Ye D; Xiong Y; Guan KL
    Genes Dev; 2012 Jun; 26(12):1326-38. PubMed ID: 22677546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the mitochondrial proteome of cybrid cells harbouring a truncative mitochondrial DNA mutation in respiratory complex I.
    Musicco C; Cormio A; Calvaruso MA; Iommarini L; Gasparre G; Porcelli AM; Timperio AM; Zolla L; Gadaleta MN
    Mol Biosyst; 2014 Jun; 10(6):1313-9. PubMed ID: 24643264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.
    MacKenzie ED; Selak MA; Tennant DA; Payne LJ; Crosby S; Frederiksen CM; Watson DG; Gottlieb E
    Mol Cell Biol; 2007 May; 27(9):3282-9. PubMed ID: 17325041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic complex I disruptive mitochondrial DNA mutations are modifiers of tumorigenesis that correlate with low genomic instability in pituitary adenomas.
    Kurelac I; MacKay A; Lambros MB; Di Cesare E; Cenacchi G; Ceccarelli C; Morra I; Melcarne A; Morandi L; Calabrese FM; Attimonelli M; Tallini G; Reis-Filho JS; Gasparre G
    Hum Mol Genet; 2013 Jan; 22(2):226-38. PubMed ID: 23049073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling.
    Bénit P; Letouzé E; Rak M; Aubry L; Burnichon N; Favier J; Gimenez-Roqueplo AP; Rustin P
    Biochim Biophys Acta; 2014 Aug; 1837(8):1330-7. PubMed ID: 24699309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of SDHB Elevates Catecholamine Synthesis and Secretion Depending on ROS Production and HIF Stabilization.
    Saito Y; Ishii KA; Aita Y; Ikeda T; Kawakami Y; Shimano H; Hara H; Takekoshi K
    Neurochem Res; 2016 Apr; 41(4):696-706. PubMed ID: 26620190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of mitochondrial genetics and metabolism in cancer development.
    Gasparre G; Porcelli AM; Lenaz G; Romeo G
    Cold Spring Harb Perspect Biol; 2013 Feb; 5(2):. PubMed ID: 23378588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations.
    Pollard PJ; Brière JJ; Alam NA; Barwell J; Barclay E; Wortham NC; Hunt T; Mitchell M; Olpin S; Moat SJ; Hargreaves IP; Heales SJ; Chung YL; Griffiths JR; Dalgleish A; McGrath JA; Gleeson MJ; Hodgson SV; Poulsom R; Rustin P; Tomlinson IP
    Hum Mol Genet; 2005 Aug; 14(15):2231-9. PubMed ID: 15987702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck.
    Zhou S; Kachhap S; Sun W; Wu G; Chuang A; Poeta L; Grumbine L; Mithani SK; Chatterjee A; Koch W; Westra WH; Maitra A; Glazer C; Carducci M; Sidransky D; McFate T; Verma A; Califano JA
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7540-5. PubMed ID: 17456604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase.
    Selak MA; Armour SM; MacKenzie ED; Boulahbel H; Watson DG; Mansfield KD; Pan Y; Simon MC; Thompson CB; Gottlieb E
    Cancer Cell; 2005 Jan; 7(1):77-85. PubMed ID: 15652751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability.
    Lehtonen HJ; Mäkinen MJ; Kiuru M; Laiho P; Herva R; van Minderhout I; Hogendoorn PC; Cornelisse C; Devilee P; Launonen V; Aaltonen LA
    Int J Cancer; 2007 Sep; 121(6):1386-9. PubMed ID: 17520677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.